Clinical Trials Logo

Clinical Trial Details — Status: Suspended

Administrative data

NCT number NCT04249414
Other study ID # PV500PERF
Secondary ID
Status Suspended
Phase
First received
Last updated
Start date January 2024
Est. completion date December 2024

Study information

Verified date March 2023
Source Drägerwerk AG & Co. KGaA
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Define the capability and reliability of the PulmoVista® 500 (PV500) to detect changes in global and regional ventilation and perfusion.


Description:

The results of this study will help defining the capability and reliability of PulmoVista® 500 (PV500) to detect changes in both global and regional ventilation and perfusion. As this is a non-invasive, observational trial, neither a positive nor a negative impact on the actual study participants is expected. The results will, however, improve the knowledge about the electrical impedance tomography (EIT) technology and thus aid the use of this technology for the benefit of future patients.


Recruitment information / eligibility

Status Suspended
Enrollment 22
Est. completion date December 2024
Est. primary completion date June 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Age 18 - 80 years - Mandatorily ventilated intensive-care patients with impairment in oxygenation (P/F ratio < 300 at PEEP = 5) ventilated at a positive end-expiratory pressure (PEEP) not exceeding 10 mbar and an fraction of inspired oxygen (FiO2) chosen, such that pulse oximetry is sensitive towards arterial oxygen pressure (PaO2) changes. - Expected ventilation time >48h - Existing central venous and arterial access - Chest circumference 70 - 150 cm - Mandatory mechanical ventilation (patients without spontaneous efforts) - Serum levels of sodium and chloride within normal range - Cardiac output monitoring in place (PICCO) Exclusion Criteria: - Contraindication to central venous injection of 5 % sodium chloride (NaCl) (e.g. elevated Na+ and/or Cl- concentration: Na+ should not exceed 150 mmol/l, Chloride should not exceed 115 mmol/l, known hypernatremia, known high serum osmolality) - Contraindications of PulmoVista 500: - Patients with pacemakers, defibrillators or other electrically active implants - Patients with damaged skin or impaired skin contact of the electrodes due to wound dressings - Patients where the attachment of the patient belt could pose a risk to the patient, e.g. patients with spinal lesions or fractures - Patients with uncontrolled body movements - Extremely obese patients (BMI>50) - Patients during pregnancy - Patients with massive lung edema - Use during electricity-based therapies, such as electrosurgery or electrocautery - Use in the presence of strong magnetic fields - Use in conjunction with other bioimpedance measurement devices - Infection or colonization with multi-resistant pathogens that require isolation of the patient (e.g. MRSA)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
PulmoVista 500
Monitoring of Ventilation and Perfusion with the PulmoVista 500 during clinical routine. No medical interventions required

Locations

Country Name City State
Germany University Medical Center Göttingen Göttingen

Sponsors (3)

Lead Sponsor Collaborator
Drägerwerk AG & Co. KGaA Prof. Dr. med. Imhoff, University of Göttingen

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Assess regional distribution of pulmonary perfusion The capability of PulmoVista® 500 for assessing regional distribution of pulmonary perfusion based on pulsatility signals and based on indicator dilution and changes at different points in time during varying states of regional ventilation will be evaluated. within 24 hours
Secondary Assess hemodynamic parameter cardiac output The capability of PulmoVista® 500 for assessing cardiac output (relative values compared to reference given in l/min) will be explored. within 24 hours
Secondary Assess hemodynamic parameter heart rate The capability of PulmoVista® 500 for assessing heart rate (1/min) will be explored. within 24 hours
Secondary Assess hemodynamic parameter stroke volume variability The capability of PulmoVista® 500 for assessing stroke volume variability (relative value in % for 30 seconds compared to reference given in ml) will be explored. within 24 hours
Secondary Assess oxygenation status The capability PulmoVista® 500 for assessing the oxygenation status from both the regional distribution of alveolar ventilation and the regional distribution of pulmonary perfusion will be explored. within 24 hours
See also
  Status Clinical Trial Phase
Completed NCT05921656 - Construction and Evaluation of Airway Leakage Risk Model of Patients With Endotracheal Tube
Recruiting NCT03941002 - Continuous Evaluation of Diaphragm Function N/A
Withdrawn NCT04288076 - The Brain and Lung Interaction (BALI) Study N/A
Completed NCT03031860 - Semi-quantitative Cough Strength Score (SCSS) N/A
Completed NCT02545621 - A Role for RAGE/TXNIP/Inflammasome Axis in Alveolar Macrophage Activation During ARDS (RIAMA): a Proof-of-concept Clinical Study
Completed NCT02312869 - Local Assessment of Management of Burn Patients N/A
Completed NCT01885442 - TryCYCLE: A Pilot Study of Early In-bed Leg Cycle Ergometry in Mechanically Ventilated Patients N/A
Completed NCT01204281 - Proportional Assist Ventilation (PAV) in Early Stage of Critically Ill Patients Phase 4
Terminated NCT01059929 - Dexmedetomidine Versus Propofol in the Medical Intensive Care Unit (MICU) Phase 4
Completed NCT00824239 - Intermittent Sedation Versus Daily Interruption of Sedation in Mechanically Ventilated Patients Phase 3
Completed NCT00529347 - Mechanical Ventilation Controlled by the Electrical Activity of the Patient's Diaphragm - Effects of Changes in Ventilator Parameters on Breathing Pattern Phase 1
Unknown status NCT00260676 - Protective Ventilatory Strategy in Potential Organ Donors Phase 3
Terminated NCT00205517 - Sedation and Psychopharmacology in Critical Care N/A
Completed NCT03281785 - Ultrasound of Diaphragmatic Musculature in Mechanically Ventilated Patients. N/A
Recruiting NCT04110613 - RCT: Early Feeding After PEG Placement N/A
Completed NCT04410783 - The Emergency Department Sedation Pilot Trial N/A
Recruiting NCT04821453 - NAVA vs. CMV Crossover in Severe BPD N/A
Completed NCT03930147 - Ventilation With ASV Mode in Children N/A
Recruiting NCT05029167 - REstrictive Versus LIberal Oxygen Strategy and Its Effect on Pulmonary Hypertension After Out-of-hospital Cardiac Arrest (RELIEPH-study) N/A
Recruiting NCT04849039 - Lung Microbiota and VAP Development (PULMIVAP)